3Knutsen AP,Freeman JJ,Mueller KR,et al.Thymosin-alpha1 stimulates maturation of CD34^+ stem cells into CD3^+ 4^+ cells in an in vitro thymic epithelia organ coculture model[J].Int J Immunopharmacol,1999,21(1):15-26.
4Silecchia G,Guarino E,Sinibaldi-Vallebona P,et al.Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery[J].Cancer Immunol Immunother,1999,48(4):172-178.
5Kawarabayashi N,Seki S,Hatsuse K,et al.Decrease of CD56(+) T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma[J].Hepatology,2000,32(5):962-969.
7Huang Y,Chen Z,Zhou C,et al.Bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha[J].Int Immunopharmacol,2004,4(4):539-546.
8Yang S,Liu ZW,Zhou WX,et al.Thymosin alpha-1 modulates excitatory synaptic transmission in cultured hippocampal neurons in rats[J].Neurosci Lett,2003,350(2):81-84.
9Sodhi A,Paul S.Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha1[J].Int Immunopharmacol,2002,2(1):47-58.
10Roy R,Singh SM,Shanker A,et al.Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host:the molecular events involved and their inhibition by thymosin alpha-1[J].Int J Immunopharmacol,2000,22(4):309-321.
6[1]Mark P, Dennis S. Biological rationale for HER2/neu as a target for monoclonal antibody therapy[J]. Seminars in Oncology, 2000, 27(5, Suppl 9): 13-19.
7[2]Ravdin PM, Chamness GC. The cerbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular marker-a review[J]. Gene, 1995, 159:19.
8[3]Fornier M, Esteva FJ, Seidman AD, et al. Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer[J]. Semin Oncol, 2000, 27(6 Suppl 11): 38- 45.
9[4]Christiane JB, Wenbiao L, Darren WD, et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases[J]. Cancer, 2000, 89: 488- 499.
10[5]Paul P, Takashi M, Keiji I, et al. Anti-epidermal growth gactor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice[J]. Clinical Cancer Research, 1999, 5: 257-264.
